These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15983678

  • 1. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.
    Al-Nozha MM, Abdel-Gader AG, Arafah MR, Al-Maatouq MA, Al-Shahid MS, Al-Harthi SS, Khan NB, Abdullah MA.
    Saudi Med J; 2005 Jun; 26(6):937-42. PubMed ID: 15983678
    [Abstract] [Full Text] [Related]

  • 2. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 3. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction.
    Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Tsoufis C, Marinou K, Charakida M, Stefanadi E, Vavuranakis M, Latsios G, Stefanadis C.
    Int J Cardiol; 2007 Feb 07; 115(2):203-7. PubMed ID: 16787670
    [Abstract] [Full Text] [Related]

  • 4. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M.
    Circulation; 2003 Dec 09; 108(23):2864-9. PubMed ID: 14656922
    [Abstract] [Full Text] [Related]

  • 5. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov 09; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 6. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, Fortmann SP, Quertermous T, Hlatky MA, Atherosclerotic Disease, Vascular Function and Genetic Epidemiology Advance (ADVANCE) Study.
    Am Heart J; 2007 Dec 09; 154(6):1059-64. PubMed ID: 18035075
    [Abstract] [Full Text] [Related]

  • 7. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction.
    Van Dreden P, Rousseau A, Savoure A, Lenormand B, Fontaine S, Vasse M.
    Blood Coagul Fibrinolysis; 2009 Dec 09; 20(8):635-41. PubMed ID: 19809306
    [Abstract] [Full Text] [Related]

  • 8. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
    Habib SS, Abdel Gader AG, Kurdi MI, Suriya MO, Al Aseri Z.
    J Pak Med Assoc; 2012 Jul 09; 62(7):681-5. PubMed ID: 23866515
    [Abstract] [Full Text] [Related]

  • 9. Laboratory markers of hypercoagulability.
    Rossi ML, Merlini PA, Ardissino D.
    Ital Heart J; 2001 Jul 09; 2(7):490-4. PubMed ID: 11501955
    [Abstract] [Full Text] [Related]

  • 10. [Effects of exercise on markers of hemostatic activation in young survivors of myocardial infarction].
    Vitsenia MV, Noeva EA, Titaeva EV, Dobrovol'skiĭ AB.
    Ter Arkh; 2004 Jul 09; 76(12):17-23. PubMed ID: 15724919
    [Abstract] [Full Text] [Related]

  • 11. [Markers of hemostasis and myocardial infarction in persons under 40 years of age].
    Guy JM, Raynaud J, Gonthier R, Kimmerle L, Favre JP, Lamaud M, Cerisier A, Verneyre H.
    Ann Cardiol Angeiol (Paris); 1993 Mar 09; 42(3):121-6. PubMed ID: 8498796
    [Abstract] [Full Text] [Related]

  • 12. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
    Tziakas DN, Chalikias GK, Parissis JT, Hatzinikolaou EI, Papadopoulos ED, Tripsiannis GA, Papadopoulou EG, Tentes IK, Karas SM, Chatseras DI.
    Int J Cardiol; 2004 Apr 09; 94(2-3):269-77. PubMed ID: 15093992
    [Abstract] [Full Text] [Related]

  • 13. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T, Gando S, Kemmotsu O, Mashio H, Goda Y, Kawahigashi H, Watanabe N.
    J Cardiothorac Vasc Anesth; 2001 Feb 09; 15(1):60-4. PubMed ID: 11254842
    [Abstract] [Full Text] [Related]

  • 14. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial.
    Fresco C, Maggioni AP, Signorini S, Merlini PA, Mocarelli P, Fabbri G, Lucci D, Tubaro M, Gattone M, Schweiger C, LATIN Investigators.
    Ital Heart J; 2002 Oct 09; 3(10):587-92. PubMed ID: 12478816
    [Abstract] [Full Text] [Related]

  • 15. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H, Ohno M, Ohashi H.
    Adv Perit Dial; 2000 Oct 09; 16():152-5. PubMed ID: 11045282
    [Abstract] [Full Text] [Related]

  • 16. [Observation on tissue factor pathway during the onset of acute cerebral infarction].
    Wen ZB, Xiong SL, He XF, He MX, He SL, Xie QZ, Jian ZF, Chen FP, Xiao B, Yang QD.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep 09; 15(9):529-31. PubMed ID: 12971845
    [Abstract] [Full Text] [Related]

  • 17. [The thrombophilic status and ischemic cardiopathy].
    Ferlito S, Torrisi A, Marangio S, Palermo A, Condorelli M, Mazzone D.
    Minerva Cardioangiol; 1991 May 09; 39(5):167-76. PubMed ID: 1956544
    [Abstract] [Full Text] [Related]

  • 18. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J, Siegbahn A, Grip L, Linder R, Thygesen K, Wallentin L.
    Thromb Haemost; 2004 Feb 09; 91(2):381-7. PubMed ID: 14961168
    [Abstract] [Full Text] [Related]

  • 19. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D, Bosinakou E, Kotsopoulou M, Antoniades C, Katsi V, Stefanadis C.
    Int J Cardiol; 2006 Jan 26; 106(3):333-7. PubMed ID: 16337041
    [Abstract] [Full Text] [Related]

  • 20. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
    Figueras J, Monasterio J, Lidón RM, Sambola A, Garcia-Dorado D.
    Thromb Res; 2012 Sep 26; 130(3):458-62. PubMed ID: 22424853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.